olarif ds (olopatadine 0.2%) ophthalmic solution launching literature presentation
TRANSCRIPT
![Page 1: Olarif DS (Olopatadine 0.2%) Ophthalmic Solution launching Literature Presentation](https://reader035.vdocument.in/reader035/viewer/2022062902/58edfcd31a28ab15368b4607/html5/thumbnails/1.jpg)
Allergies
![Page 2: Olarif DS (Olopatadine 0.2%) Ophthalmic Solution launching Literature Presentation](https://reader035.vdocument.in/reader035/viewer/2022062902/58edfcd31a28ab15368b4607/html5/thumbnails/2.jpg)
Ocular Allergies
![Page 3: Olarif DS (Olopatadine 0.2%) Ophthalmic Solution launching Literature Presentation](https://reader035.vdocument.in/reader035/viewer/2022062902/58edfcd31a28ab15368b4607/html5/thumbnails/3.jpg)
More than 20% population of the world is usually affected by different types of Ocular Allergies.
Allergic conjunctivitis is the most common and the most irritating one.
![Page 4: Olarif DS (Olopatadine 0.2%) Ophthalmic Solution launching Literature Presentation](https://reader035.vdocument.in/reader035/viewer/2022062902/58edfcd31a28ab15368b4607/html5/thumbnails/4.jpg)
Conjunctivitis
Inflammation of the conjunctiva is called conjunctivitis
1. Bacterial Conjunctivitis2. Viral Conjunctivitis3. Allergic Conjunctivitis
![Page 5: Olarif DS (Olopatadine 0.2%) Ophthalmic Solution launching Literature Presentation](https://reader035.vdocument.in/reader035/viewer/2022062902/58edfcd31a28ab15368b4607/html5/thumbnails/5.jpg)
Allergic conjunctivitis is inflammation of the conjunctiva due to allergic activities
Allergic Conjunctivitis
![Page 6: Olarif DS (Olopatadine 0.2%) Ophthalmic Solution launching Literature Presentation](https://reader035.vdocument.in/reader035/viewer/2022062902/58edfcd31a28ab15368b4607/html5/thumbnails/6.jpg)
Allergic Conjunctivitis
![Page 7: Olarif DS (Olopatadine 0.2%) Ophthalmic Solution launching Literature Presentation](https://reader035.vdocument.in/reader035/viewer/2022062902/58edfcd31a28ab15368b4607/html5/thumbnails/7.jpg)
![Page 8: Olarif DS (Olopatadine 0.2%) Ophthalmic Solution launching Literature Presentation](https://reader035.vdocument.in/reader035/viewer/2022062902/58edfcd31a28ab15368b4607/html5/thumbnails/8.jpg)
Ensures excellent efficacy and greater tolerability2
…greater patient satisfaction by rapid symptomatic relief
![Page 9: Olarif DS (Olopatadine 0.2%) Ophthalmic Solution launching Literature Presentation](https://reader035.vdocument.in/reader035/viewer/2022062902/58edfcd31a28ab15368b4607/html5/thumbnails/9.jpg)
•The best option for Allergic
Conjunctivitis treatment
•Better than Ephinastine in preventing
ocular itching & redness
•Ensures excellent efficacy and greater
tolerability
•Safe for children and adolescent
•Safe for long term use
![Page 10: Olarif DS (Olopatadine 0.2%) Ophthalmic Solution launching Literature Presentation](https://reader035.vdocument.in/reader035/viewer/2022062902/58edfcd31a28ab15368b4607/html5/thumbnails/10.jpg)
Major indications:
1. Seasonal allergic conjunctivitis
2. Perennial allergic conjunctivitis
3. Allergic Keratitis
4. Allergic Kerato-conjunctivitis
![Page 11: Olarif DS (Olopatadine 0.2%) Ophthalmic Solution launching Literature Presentation](https://reader035.vdocument.in/reader035/viewer/2022062902/58edfcd31a28ab15368b4607/html5/thumbnails/11.jpg)
Product Positioning
Physician Positions1. Ophthalmologist Allergic conjunctivitis, Allergic
Keratitis , Allergic Kerato-conjunctivitis
2. Pediatricians Pediatrici allergic conjunctivitis and keratitis
3. Potential GP & Medicine Sp. Allergic conjunctivitis, Allergic Keratitis , Allergic Kerato-conjunctivitis
![Page 12: Olarif DS (Olopatadine 0.2%) Ophthalmic Solution launching Literature Presentation](https://reader035.vdocument.in/reader035/viewer/2022062902/58edfcd31a28ab15368b4607/html5/thumbnails/12.jpg)
Action Plan• Select Five doctors of your territory who are
prescribing Olopatadine DS
• Convey the special advantages of Olarif DS over
the competitor’s brands.
• Visit these doctors frequently until prescription
is achieved.
• Monitor prescription share of loyal doctors
• Make the best use of physician’s sample and
promotional tools to the target doctors for
increasing prescription support
![Page 13: Olarif DS (Olopatadine 0.2%) Ophthalmic Solution launching Literature Presentation](https://reader035.vdocument.in/reader035/viewer/2022062902/58edfcd31a28ab15368b4607/html5/thumbnails/13.jpg)
![Page 14: Olarif DS (Olopatadine 0.2%) Ophthalmic Solution launching Literature Presentation](https://reader035.vdocument.in/reader035/viewer/2022062902/58edfcd31a28ab15368b4607/html5/thumbnails/14.jpg)
![Page 15: Olarif DS (Olopatadine 0.2%) Ophthalmic Solution launching Literature Presentation](https://reader035.vdocument.in/reader035/viewer/2022062902/58edfcd31a28ab15368b4607/html5/thumbnails/15.jpg)
![Page 16: Olarif DS (Olopatadine 0.2%) Ophthalmic Solution launching Literature Presentation](https://reader035.vdocument.in/reader035/viewer/2022062902/58edfcd31a28ab15368b4607/html5/thumbnails/16.jpg)
![Page 17: Olarif DS (Olopatadine 0.2%) Ophthalmic Solution launching Literature Presentation](https://reader035.vdocument.in/reader035/viewer/2022062902/58edfcd31a28ab15368b4607/html5/thumbnails/17.jpg)
THANK YOU